Proper Name: Anti-thymocyte Globulin (Rabbit)
Manufacturer: Genzyme Corporation
- An immunoglobulin G indicated for the prophylaxis and treatment of acute rejection in patients receiving a kidney transplant. Use in conjunction with concomitant immunosuppression.
- April 21, 2017 Approval Letter - Thymoglubin
- April 21, 2017 Summary Basis for Regulatory Action - Thymoglobulin
- Supporting Documents older than three years - Thymoglobulin